THERAPEUTIC DRUG MONITORING STUDY ON COFORMULATED 600-MG EFAVIRENZ, 300-MG TENOFOVIR DISOPROXIL FUMARATE AND 300-MG LAMIVUDINE AMONG HIV-POSITIVE PATIENTS WITH IMMUNE SUPPRESSION
OSHIM, I. O., ERHUNMWUNSE, R. U., OBI, C. M., ODEYEMI, O. AND OKWELOGU, I. S.
ABSTRACT
Background: Combination of three antiviral drugs are used to treat adult and adolescent HIV
infection. These antiretroviral drugs stop an enzyme (reverse transcriptase) that HIV uses to
replicate itself. By doing this, they stop the infection from spreading. Objectives: the study is
aimed at evaluating therapeutic drug monitoring on co-formulated 600-mg efavirenz, 300-mg
tenofovir disoproxil fumarate and 300-mg lamivudine among HIV-positive patients. Methods: A
Retrospective….